# Chidamide Combination With R-mini CHOP Followed by Chidamide+CD20 Maintenance in Elderly Newly Diagnosed MYC/BCL2+ DLBCL

> **NCT07493148** · PHASE2 · RECRUITING · sponsor: **Ou Bai, MD/PHD** · enrollment: 50 (estimated)

## Conditions studied

- Diffuse Large B-Cell Lymphoma (DLBCL)

## Interventions

- **DRUG:** Chidamide
- **DRUG:** Rituximab
- **DRUG:** Cyclophosphamide
- **DRUG:** Doxorubicin
- **DRUG:** Vincristine
- **DRUG:** Prednisone
- **DRUG:** Chidamide + Rituximab maintenance

## Key facts

- **NCT ID:** NCT07493148
- **Lead sponsor:** Ou Bai, MD/PHD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-30
- **Primary completion:** 2029-12-30
- **Final completion:** 2029-12-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07493148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07493148, "Chidamide Combination With R-mini CHOP Followed by Chidamide+CD20 Maintenance in Elderly Newly Diagnosed MYC/BCL2+ DLBCL". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07493148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*